TipHub

537.95

+4.38 +0.82%

29 Jul 2026

NSE Listed · Pharmaceuticals

Unichem Laboratories Ltd. (UNICHEMLAB)

Volume: 7,666Avg Vol 1W: 78,091Avg Vol 1M: 7,93,19452W Range:278.2687.2
Market Cap₹3,787 Cr
Current Price₹537.95
Previous Close₹533.57
High / Low (52w)₹687.2 / ₹278.2
Volume7,666
Avg Vol (1W)78,091
Avg Vol (1M)7,93,194
Stock P/E46.26
Book Value₹385.97
Dividend Yield0%
ROE288.06%
ROA6.77%
Revenue (TTM)
Revenue Growth18.25%
Profit Margin11.48%
Total Debt₹61 Cr
Shares Outstanding7 Cr
Face Value₹2
EPS (TTM)₹11.63
P/B1.39
Debt / Equity0.19
50 DMA₹465.4
200 DMA₹418.27
Day change+0.82%
Price Chart
537.95 14.13% · 1Y
6872842.5Cr
2025-07-29
2026-07-29

20-day avg volume: 8.6L shares

Pros
  • Healthy return on equity of 288.1%.
  • Company is almost debt-free.
  • Revenue grew 536% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹483 Cr₹507 Cr₹533 Cr₹587 Cr₹527 Cr₹579 Cr₹521 Cr₹575 Cr
EBITDA₹12 Cr₹32 Cr₹69 Cr₹63 Cr₹-2 Cr₹56 Cr₹25 Cr₹41 Cr
Net Profit₹2 Cr₹25 Cr₹58 Cr₹53 Cr₹-10 Cr₹-12 Cr₹264 Cr₹11 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹448 Cr₹2,146 Cr₹461 Cr₹384 Cr₹357 Cr₹315 Cr₹2,265 Cr₹356 Cr
EBITDA₹65 Cr₹176 Cr₹54 Cr₹0 Cr₹-1 Cr₹-14 Cr₹122 Cr₹6 Cr
Net Profit₹47 Cr₹138 Cr₹51 Cr₹-2 Cr₹-40 Cr₹216 Cr₹253 Cr₹-15 Cr
EPS19.4735.85
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹3,150 Cr₹3,145 Cr₹3,126 Cr₹3,319 Cr₹3,193 Cr₹3,275 Cr₹3,569 Cr₹3,737 Cr
Total Liabilities₹530 Cr₹613 Cr₹569 Cr₹700 Cr₹758 Cr₹837 Cr₹1,119 Cr₹1,020 Cr
Equity₹2,620 Cr₹2,531 Cr₹2,557 Cr₹2,618 Cr₹2,435 Cr₹2,438 Cr₹2,451 Cr₹2,717 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-316 Cr₹24 Cr₹47 Cr₹-252 Cr₹-73 Cr₹20 Cr₹9 Cr₹11 Cr
Investing₹-286 Cr₹-36 Cr₹-74 Cr₹102 Cr₹203 Cr₹50 Cr₹-241 Cr₹192 Cr
Financing₹-2 Cr₹-62 Cr₹-121 Cr₹191 Cr₹-81 Cr₹-106 Cr₹184 Cr₹2 Cr
Free Cash Flow₹-316 Cr₹24 Cr₹47 Cr₹-252 Cr₹-73 Cr₹20 Cr₹9 Cr₹11 Cr
Shareholding
Promoter 70.22% Institutions 11.36% Public 18.42%
Efficiency & Working Capital
ROCE3.8%
Interest Coverage4
Dividend Payout
Debtor Days137 d
Inventory Days162 d
Payable Days59 d
Cash Conversion Cycle240 d
Working Capital Days299 d
Shareholding Details

As of 2026-06-30

Promoter70.2%
FII0.9%
DII10.5%
Institutions11.4%
Public18.4%
Promoter Pledge0%
No. of Shareholders25,347
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters70.2%70.2%70.2%70.2%70.2%70.2%70.2%70.2%70.2%70.2%70.2%70.2%
FIIs0.8%0.8%0.9%0.9%0.9%1.1%1%1%1%1%1%0.9%
DIIs10.3%9.3%11.3%11.6%11.7%11.6%11.3%10.9%10.7%10.7%10.6%10.5%
Public18.6%19.6%17.6%17.3%17.2%17.1%17.5%17.9%18%18%18.1%18.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders21,58420,87721,17120,62120,37421,47221,62123,01023,57723,26723,38625,347
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Ipca Laboratories LimitedShareholding of Promoter and Promoter Group52.7%3.71 Cr
Dr. Prakash Amrut ModyShareholding of Promoter and Promoter Group12.8%89,97,952
Hdfc Small Cap FundPublic Shareholding7.8%54,58,645
Anita Prakash ModyShareholding of Promoter and Promoter Group1.9%13,23,400
Dsp Healthcare FundPublic Shareholding1.6%11,00,697
Suparna Prakash ModyShareholding of Promoter and Promoter Group1.4%9,49,936
Supriya Prakash ModyShareholding of Promoter and Promoter Group1.4%9,49,936
Dr. Prakash Amrut Mody - Suparna Mody Trust (promoter Trust )Shareholding of Promoter and Promoter Group0.1%52,016
Dr. Prakash Amrut Mody - Supriya Mody Trust (promoter Trust)Shareholding of Promoter and Promoter Group0.1%45,052
Dr. Prakash Amrut Mody - Shwetambari Mody Trust (promoter Trust)Shareholding of Promoter and Promoter Group0.1%41,283
The Hongkong And Shanghai Banking Corp.ltd.Public Shareholding0%500
Board of Directors
NameDesignationYear
Prakash A ModyChairman(Non Exe)&Dir(Non-Ind)2026
Pabitra BhattacharyaManaging Director & CEO2026
Pranay GodhaNon-Exec & Non-Independent Dir2026
Anand T KusreIndependent Non Exe. Director2026
Arun TodarwalIndependent Non Exe. Director2026
Swati PatankarIndependent Non Exe. Director2026
Pradeep BhandariHEAD - LEGAL / CS / CHIEF COMPLIANCE OFFICER2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr
Segments — Geography
RegionRevenueShare
Domestic₹33 Cr2.4%
Americas₹916 Cr66.9%
Europe₹301 Cr22%
Africa₹52 Cr3.8%
Asia₹58 Cr4.3%
CIS₹9 Cr0.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2351414
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20262,612007332,651
20264880000488
202648100720507
Insider / Designated-Person Trades

30 recent disclosure(s)

JATIN RAMANLAL MEHTADisposal · 13,200
GERARD MAJELLA COLEDisposal · 4,646
RAJARAM PAIDisposal · 4,000
IPCA LABORATORIES LIMITEDAcquisition · 1,35,79,571
VANDANA PANDEYDisposal · 6,000
DILIP KUNKOLIENKARDisposal · 5,000
Substantial Acquisitions (SAST)

2 disclosure(s)

Open Offer21/09/2023 · 1,35,79,571
Market10/01/2022 · 54,850
Company Information
Incorporated1962
ChairmanPrakash A Mody
AuditorN A Shah Associates LLP
Investor Email[email protected]
🌐 www.unichemlabs.com

📍 47 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search